EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer

Summary

This laboratory study is using EF5 to evaluate tumor hypoxia in patients with high-grade soft tissue sarcoma or mouth cancer. Using the drug EF5 to measure the oxygen level in tumor cells may help in planning cancer treatment

Timeline

Start

2001-08

Primary completion

2007-09

Completion

—

Outcome

Outcome not reported

Stopped: “Administratively complete.”

Drugs

Indications